Pulmonary Tuberculosis Clinical Trials

10 recruiting

Pulmonary Tuberculosis Trials at a Glance

16 actively recruiting trials for pulmonary tuberculosis are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Phase 2 with 8 trials, with the heaviest enrollment activity in Cape Town, Johannesburg, and Beijing. Lead sponsors running pulmonary tuberculosis studies include Gates Medical Research Institute, Obafemi Awolowo University Teaching Hospital, and ChromX Health.

Browse pulmonary tuberculosis trials by phase

Treatments under study

About Pulmonary Tuberculosis Clinical Trials

Looking for clinical trials for Pulmonary Tuberculosis? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pulmonary Tuberculosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pulmonary Tuberculosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Phase 2

Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis

Drug Susceptible Pulmonary Tuberculosis
Gates Medical Research Institute150 enrolled13 locationsNCT07525427
Recruiting
Phase 2

Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis

Drug Susceptible Pulmonary Tuberculosis
Gates Medical Research Institute165 enrolled4 locationsNCT07517445
Recruiting
Phase 2

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID)315 enrolled29 locationsNCT06192160
Recruiting
Phase 3

A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc.532 enrolled33 locationsNCT07209761
Recruiting
Phase 2

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

TuberculosisMultidrug Resistant Pulmonary Tuberculosis
WestVac Biopharma Co., Ltd.60 enrolled7 locationsNCT07170800
Recruiting
Phase 2

ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)

Pulmonary Tuberculosis (TB)
Obafemi Awolowo University Teaching Hospital80 enrolled3 locationsNCT07303699
Recruiting
Phase 3

A PAN-USR TB Multi-Center Trial

Pulmonary Tuberculosis
Shenzhen Third People's Hospital610 enrolled3 locationsNCT06905522
Recruiting
Phase 2

PanACEA - STEP2C -01

Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher390 enrolled10 locationsNCT05807399
Recruiting
Phase 2

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Pulmonary Tuberculosis
University College, London2,500 enrolled11 locationsNCT06114628
Recruiting
Phase 2

ATORvastatin in Pulmonary TUBerculosis

TuberculosisPulmonary TuberculosisKoch's Disease
Obafemi Awolowo University Teaching Hospital440 enrolled8 locationsNCT06199921
Recruiting
Phase 3

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd450 enrolled2 locationsNCT05824871
Recruiting

Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

Lung CancerLung InfectionCOPD+13 more
ChromX Health10,000 enrolled1 locationNCT06528418
Recruiting
Phase 3

Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial

Pulmonary Tuberculosis
Kaohsiung Veterans General Hospital.270 enrolled8 locationsNCT06727864
Recruiting

A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis

Extrapulmonary Tuberculosis
University of Cologne150 enrolled6 locationsNCT06875336
Recruiting
Phase 4

The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)

Pulmonary Tuberculosis
Beijing Chest Hospital45 enrolled7 locationsNCT06476210
Recruiting
Not Applicable

Rehabilitation of People With Post-tuberculosis Lung Disease

Pulmonary Tuberculosis
Centro Universitário Augusto Motta40 enrolled2 locationsNCT06127641